THE EFFECTIVENESS OF TREATMENT OF DRUGSENSITIVE TUBERCULOSIS, COMBINED WITH HIV INFECTION, IN THE TB FACILITY OF THE FEDERAL PENITENTIARY SERVICE
https://doi.org/10.22328/2077-9828-2017-9-4-33-40
Abstract
Goal: The effectiveness of treatment of drug-sensitive tuberculosis, combined with HIV infection in the TB facility of the Federal Penitentiary Service. Materials and methods. 81 men with drug-sensitive tuberculosis with HIV co-infection. Age: from 20 to 49. Results. In 50% of patients with drug-susceptible tuberculosis, co-infected with HIV in a TB institution of the Federal Penitentiary Service, bacterial excretion will be stopped by microscopy and sowing for 3 and 2 months using first-line or combination first-line and second-line anti-tuberculosis drugs in the initial regimen, respectively. The decay cavities will be closed for 5 months with initial treatment only first-line anti-tuberculosis drugs and 3 months for initial treatment with a combination of first-line and second-line anti-tuberculosis drugs.
About the Author
V. S. Borovitsky
Tuberculosis hospital FKUZ Medical-sanitary unit № 43 of the Federal Penitentiary Service of Russia, Kirovo-Chepetsk
Russian Federation
Russian Federation
References
1. Word Health Organization. Anti-tuberculosis drug resistance in the world. Geneva: WHO Press, 1997.
2. World Health Organization. The stop TB strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva: WHO Press, 2006.
3. Ahuja S.D., Ashkin D., Avendano M., Banerjee R., Bauer M., Bayona J.N. et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med., 2012, No. 9, pp. e1001300.
4. Mesfin Y.M., Hailemariam D., Biadgilign S., Kibret K.T. Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One, 2014, No. 9, pp. e82235.
5. World Health Organization. Guidelines for the programatic management of drug-resistant tuberculosis. Emergency update. WHO/HTM/TB/2008.402. Geneva, Switzerand: WHO, 2009.
6. Салина Т.Ю., Морозова Т.И. Клинические проявления и эффективность лечения больных коинфекцией туберкулез/ВИЧ-инфекция и гепатит // Туберкулез и болезни легких. 2017. № 9. С. 25–29. [Salina T.Yu., Morozova T.I. Clinical manifestations and efficacy of treatment of patients with co-infection tuberculosis/HIV and hepatitis. Tuberculosis and Lung Disease, 2017, No. 9, pp. 25–29 (In Russ.)].
7. Иванов А.К., Шевырева Е.В., Скрынник Н.А., Турсунова Н.А. Лечение больных туберкулезом и ВИЧ-инфекцией в стационаре дневного пребывания противотуберкулезного диспансера // Медицинский альянс. 2015. № 4. С. 53–59. [Ivanov A.K., Shevyreva E.V., Skrynnik N.A., Tursunova N.A. The treatment of patients with tuberculosis and HIV in a hospital day stay TB dispensary. Medical Alliance, 2015, No. 4, pp. 53–59 (In Russ.)].
8. Астровко А.П., Скрягина Е.М., Гуревич Г.Л., Богомазова А.В., Дюсьмикеева М.И., Фисенко Е.Г. Результаты эпиднадзора ВИЧ-ассоции- рованного туберкулеза в республике Беларусь // Туберкулез и болезни легких. 2014. № 6. С. 17–21. [Astrovko A.P., Skryagina E.M., Gurevich G.L., Bogomazov A.V., Diusmikeeva M.I., Fisenko E.G. The results of the surveillance of HIV-associated tuberculosis in the Republic of Belarus. Tuberculosis and Lung Disease, 2014, No. 6, pp. 17–21 (In Russ.)].
9. Мордык А.В., Пузырева Л.В., Ситникова С.В. Опыт применения противотуберкулезной и антиретровирусной терапии у больных туберкулезом с ВИЧ-инфекцией // Журнал инфектологии. 2014. Т. 6, № 3. С. 51–55. [Mordyk A.V., Puzyreva L.V., Sitnikova S.V. Experience of application of anti-TB and antiretroviral therapy in TB patients with HIV infection. Journal of Infectology, 2014, Vol. 6, No. 3, pp. 51–55 (In Russ.)].
10. Черенько С.А., Роенко Г.Н., Погребная М.В., Сенько Ю.А., Марченко Н.А. Применение моксифлоксацина для лечения больных с новыми случаями коинфекции туберкулез/ВИЧ // Туберкулез, легочные болезни, ВИЧ-инфекция. 2013. № 4 (15). С. 24–30. [Cheren’ko S.A., Royenko G.N., Pogrebnaya M.V., Sen’ko Yu.A., Marchenko N.A. The use of moxifloxacin for the treatment of patients with new cases of co-infection tuberculosis/HIV. Tuberculosis, Pulmonary Disease, HIV Infection, 2013, No. 4 (15), pp. 24–30 (In Russ.)].
11. Черенько С.А., Роенко Г.Н., Погребная М.В. Особенности течения рецидивов туберкулеза у ВИЧ-инфицированных и результаты их лечения // Туберкулез, легочные болезни, ВИЧ-инфекция. 2012. № 4 (11). С. 13–19. [Cheren’ko S.A., Royenko G.N., Pogrebnaya M.V. Peculiarities of the course of recurrences of tuberculosis in HIV-infected and their treatment outcomes. Tuberculosis, Pulmonary Diseases, HIV Infection, 2012, No. 4 (11), pp. 13–19 (In Russ.)].
12. Сергиенко В.И., Бондарева И.Б. Математическая статистика в клинических исследованиях. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2006. 304 с. [Sergienko V.I., Bondareva I.B. Mathematical statistics in clinical research. 2nd ed., rev. Moscow: GEOTAR-Media, 2006, 304 p. (In Russ.)].
Review
For citations:
Borovitsky V.S. THE EFFECTIVENESS OF TREATMENT OF DRUGSENSITIVE TUBERCULOSIS, COMBINED WITH HIV INFECTION, IN THE TB FACILITY OF THE FEDERAL PENITENTIARY SERVICE. HIV Infection and Immunosuppressive Disorders. 2017;9(4):33-40. (In Russ.) https://doi.org/10.22328/2077-9828-2017-9-4-33-40
Views:
689
.png)
Email this article 